Early and Late Molecular Events in Neurodegeneration and Neuroprotection in Parkinson's Disease MPTP Model as Assessed by cDNA Microarray; the Role of Iron

References

• Ara , J. , Przedborski , S. , Naini , A.B. , Jackson-Lewis , V. , Trifiletti , R.R. , Horwitz , J. and Ischiropoulos , H. 1998 . "Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)" . Proc. Natl Acad. Sci. USA , 95 : 7659 – 7663 .
   PubMed Web of Science ®Google Scholar
• Arawaka , S. , Saito , Y. , Murayama , S. and Mori , H. 1998 . "Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for alpha-synuclein" . Neurology , 51 : 887 – 889 .
   PubMed Web of Science ®Google Scholar
• Ben-Shachar , D. , Eshel , G. , Finberg , J.P. and Youdim , M.B. 1991 . "The iron chelator desferrioxamine (Desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons" . J. Neurochem. , 56 : 1441 – 1444 .
   PubMed Web of Science ®Google Scholar
• Berg , D. , Gerlach , M. , Youdim , M.B.H. , Double , K.L. , Zecca , L. , Riederer , P. and Becker , G. 2001 . "Brain iron pathways and their relevance to Parkinson's disease" . J. Neurochem. , 79 : 225 – 236 .
   PubMed Web of Science ®Google Scholar
• Bessler , H. , Djaldetti , R. , Salman , H. , Bergman , M. and Djaldetti , M. 1999 . "IL-1 beta, IL-2, IL-6 and TNF-alpha production by peripheral blood mononuclear cells from patients with Parkinson's disease" . Biomed. Pharmacother. , 53 : 141 – 145 .
   PubMed Web of Science ®Google Scholar
• Cadet , J.L. , Jayanthi , S. , McCoy , M.T. , Vawter , M. and Ladenheim , B. 2001 . "Temporal profiling of methamphetamine-induced changes in gene expression in the mouse brain: evidence from cDNA array" . Synapse , 41 : 40 – 48 .
   PubMed Web of Science ®Google Scholar
• Debouck , C. and Goodfellow , P.N. 1999 . "DNA microarrays in drug discovery and development" . Nat. Genet. , 21 : 48 – 50 .
   PubMed Web of Science ®Google Scholar
• Ebadi , M. , Govitrapong , P. , Sharma , S. , Muralikrishnan , D. , Shavali , S. , Pellett , L. , Schafer , R. , Albano , C. and Eken , J. 2001 . "Ubiquinone (coenzyme q10) and mitochondria in oxidative stress of Parkinson's disease" . Biol. Signals Recept. , 10 : 224 – 253 .
   PubMedGoogle Scholar
• Gassen , M. , Gross , A. and Youdim , M.B. 1998 . "Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H 2 O 2 and 6-hydroxydopamine" . Mov. Disord. , 13 : 242 – 248 .
   PubMed Web of Science ®Google Scholar
• Gerlach , M. , Ben-Shachar , D. , Riederer , P. and Youdim , M.B.H. 1994 . "Altered brain metabolism of iron as a cause of neurodegenerative diseases?" . J. Neurochem. , 793 : 793 – 807 .
   Google Scholar
• Grunblatt , E. , Mandel , S. , Berkuzki , T. and Youdim , M.B.H. 1999 . "Apomorphine protects against MPTP-induced neurotoxicity in mice" . Mov. Disord. , 14 : 612 – 618 .
   PubMed Web of Science ®Google Scholar
• Grunblatt , E. , Mandel , S. , Maor , G. and Youdim , M.B.H. 2001a . "Effects of R -apomorphine and S -apomorphine on MPTP-induced nigro-striatal doamine neuronal loss" . J. Neurochem. , 77 : 146 – 156 .
   PubMed Web of Science ®Google Scholar
• Grunblatt , E. , Mandel , S. , Maor , G. and Youdim , M.B.H. 2001b . "Gene expression analysis in MPTP mice model of Parkinson's disease using cDNA microarray" . J. Neurochem. , 78 : 1 – 12 .
   PubMed Web of Science ®Google Scholar
• Gunshin , H. , Mackenzie , B. , Berger , U.V. , Gunshin , Y. , Romero , M.F. , Boron , W.F. , Nussberger , S. , Gollan , J.L. and Hediger , M.A. 1997 . "Cloning and characterization of a mammalian proton-coupled metal-ion transporter" . Nature , 388 : 482 – 488 .
   PubMed Web of Science ®Google Scholar
• Hadjiconstantinou , M. , Fitkin , J.G. , Dalia , A. and Neff , N.H. 1991 . "Epidermal growth factor enhances striatal dopaminergic parameters in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse" . J. Neurochem. , 57 : 479 – 482 .
   PubMed Web of Science ®Google Scholar
• Hanson , E.S. and Leibold , E.A. 1999 . "Regulation of the iron regulatory proteins by reactive nitrogen and oxygen species" . Gene Expr. , 7 : 367 – 376 .
   PubMed Web of Science ®Google Scholar
• Hentze , M.W. and Kuhn , L.C. 1996 . "Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress" . Proc. Natl Acad. Sci. USA , 93 : 8175 – 8182 .
   PubMed Web of Science ®Google Scholar
• Hunot , S. , Brugg , B. , Ricard , D. , Michel , P.P. , Muriel , M.P. , Ruberg , M. , Faucheux , B.A. , Agid , Y. and Hirsch , E.C. 1997 . "Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with Parkinson disease" . Proc. Natl Acad. Sci. USA , 94 : 7531 – 7536 .
   PubMed Web of Science ®Google Scholar
• Ishii , T. , Yanagawa , T. , Yuki , K. , Kawane , T. , Yoshida , H. and Bannai , S. 1997 . "Low micromolar levels of hydrogen peroxide and proteasome inhibitors induce the 60-kDa A170 stress protein in murine peritoneal macrophages" . Biochem. Biophys. Res. Commun. , 232 : 33 – 37 .
   PubMed Web of Science ®Google Scholar
• Jellinger , K.A. 2001 . "The pathology of Parkinson's disease" . Adv. Neurol. , 86 : 55 – 72 .
   PubMedGoogle Scholar
• Jellinger , K. , Paulus , W. , Grundke-Iqbal , I. , Riederer , P. and Youdim , M.B.H. 1990 . "Brain iron and ferritin in Parkinson's and Alzheimer's diseases" . J. Neural Transm. Parkinson's Dis. Dementia Sect. , 2 : 327 – 340 .
   PubMedGoogle Scholar
• Kim , S. and Ponka , P. 1999 . "Control of transferrin receptor expression via nitric oxide-mediated modulation of iron-regulatory protein 2" . J. Biol. Chem. , 274 : 33035 – 33042 .
   PubMed Web of Science ®Google Scholar
• Kim , S. and Ponka , P. 2000 . "Effects of interferon-gamma and lipopolysaccharide on macrophage iron metabolism are mediated by nitric oxide-induced degradation of iron regulatory protein 2" . J. Biol. Chem. , 275 : 6220 – 6226 .
   PubMed Web of Science ®Google Scholar
• Kumer , S.C. and Vrana , K.E. 1996 . "Intricate regulation of tyrosine hydroxylase activity and gene expression" . J. Neurochem. , 67 : 443 – 462 .
   PubMed Web of Science ®Google Scholar
• Lander , E.S. , Linton , L.M. , Birren , B. Nusbaum , C. 2001 . "Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease" . Nat. Genet. , 28 : 350 – 354 .
   Google Scholar
• LaVaute , T. , Smith , S. , Cooperman , S. , Iwai , K. , Land , W. , Meyron-Holtz , E. , Drake , S.K. , Miller , G. , Abu-Asab , M. , Tsokos , M. , Switzer , R. 3rd , Grinberg , A. , Love , P. , Tresser , N. and Rouault , T.A. 2001 . "Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice" . Nat. Genet. , 27 : 209 – 214 .
   PubMed Web of Science ®Google Scholar
• Levites , Y. , Youdim , M.B.H. , Maor , G. and Mandel , S. 2002 . "Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-kappaB) activation and cell death by tea extracts in neuronal cultures" . Biochem. Pharmacol. , 63 : 21 – 29 .
   PubMed Web of Science ®Google Scholar
• Lin , L.F. , Doherty , D.H. , Lile , J.D. , Bektesh , S. and Collins , F. 1993 . "GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons [see comments]" . Science , 260 : 1130 – 1132 .
   PubMed Web of Science ®Google Scholar
• Lin , M. , Rippe , R.A. , Niemela , O. , Brittenham , G. and Tsukamoto , H. 1997 . "Role of iron in NF-kappa B activation and cytokine gene expression by rat hepatic macrophages" . Am. J. Physiol. , 272 : G1355 – G1364 .
   PubMed Web of Science ®Google Scholar
• Mandel , S. , Grunblatt , E. and Youdim , M.B.H. 2000a . "cDNA microarray to study gene expression of dopaminergic neurodegeneration and neuroprotection in MPTP and 6-hydroxydopamine models: implications for idiopathic Parkinson's disease" . J. Neural. Transm. Suppl. , 60 : 117 – 124 .
   Google Scholar
• Mandel , S. , Levites , Y. , Maor , G. and Youdim , M.B.H. 2000b . "Neuroprotection by black and green tea extracts involves inhibition of translocation and activity of NFkappaB in neuronal cells" . Neurosci. Lett. , : 55
   Google Scholar
• Mandel , S. , Grunblatt , E. , Levites , Y. , Maor , G. and Youdim , M.B.H. 2002a . "Molecular events in neurodegeneration and neuroprotection in Parkinson's Disease and its animal model MPTP as assessed by cDNA microarray" . Adv. Neurol. , In Press
   Google Scholar
• Mandel , S. , Grunblatt , E. , Maor , G. and Youdim , M.B.H. 2002b . "Early and late gene changes in MPTP mice model of Parkinson's disease employing cDNA microarray" . Neurochem. Res. , In-Press
   Google Scholar
• Mochizuki , H. , Imai , H. , Endo , K. , Yokomizo , K. , Murata , Y. , Hattori , N. and Mizuno , Y. 1994 . "Iron accumulation in the substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced hemiparkinsonian monkeys" . Neurosci. Lett. , 168 : 251 – 253 .
   PubMed Web of Science ®Google Scholar
• Mogi , M. , Harada , M. , Narabayashi , H. , Inagaki , H. , Minami , M. and Nagatsu , T. 1996 . "Interleukin (IL)-1 beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease" . Neurosci. Lett. , 211 : 13 – 16 .
   PubMed Web of Science ®Google Scholar
• Mogi , M. , Togari , A. , Ogawa , M. , Ikeguchi , K. , Shizuma , N. , Fan , D. , Nakano , I. and Nagatsu , T. 1998 . "Effects of repeated systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to mice on interleukin-1beta and nerve growth factor in the striatum" . Neurosci. Lett. , 250 : 25 – 28 .
   PubMed Web of Science ®Google Scholar
• Monteiro , H.P. and Winterbourn , C.C. 1989 . "6-Hydroxydopamine releases iron from ferritin and promotes ferritin-dependent lipid peroxidation" . Biochem. Pharmacol. , 38 : 4177 – 4182 .
   PubMed Web of Science ®Google Scholar
• Ostrerova-Golts , N. , Petrucelli , L. , Hardy , J. , Lee , J.M. , Farer , M. and Wolozin , B. 2000 . "The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity" . J. Neurosci. , 20 : 6048 – 6054 .
   PubMed Web of Science ®Google Scholar
• Rathke-Hartlieb , S. , Kahle , P.J. , Neumann , M. , Ozmen , L. , Haid , S. , Okochi , M. , Haass , C. and Schulz , J.B. 2001 . "Sensitivity to MPTP is not increased in Parkinson's disease-associated mutant alpha-synuclein transgenic mice" . J. Neurochem. , 77 : 1181 – 1184 .
   Google Scholar
• Santos , B.C. , Chevaile , A. , Kojima , R. and Gullans , S.R. 1998 . "Characterization of the Hsp110/SSE gene family response to hyperosmolality and other stresses" . Am. J. Physiol. , 274 : F1054 – F1061 .
   PubMedGoogle Scholar
• Schneider , B.D. and Leibold , E.A. 2000 . "Regulation of mammalian iron homeostasis" . Curr. Opin. Clin. Nutr. Metab. Care , 3 : 267 – 273 .
   Google Scholar
• Schreck , R. , Rieber , P. and Baeuerle , P.A. 1991 . "Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1" . EMBO J. , 10 : 2247 – 2258 .
   PubMed Web of Science ®Google Scholar
• Sofic , E. , Paulus , W. , Jellinger , K. , Riederer , P. and Youdim , M.B.H. 1991 . "Selective increase of iron in substantia nigra zona compacta of parkinsonian brains" . J. Neurochem. , 56 : 978 – 982 .
   PubMed Web of Science ®Google Scholar
• Temlett , J.A. , Landsberg , J.P. , Watt , F. and Grime , G.W. 1994 . "Increased iron in the substantia nigra compacta of the MPTP-lesioned hemiparkinsonian African green monkey: evidence from proton microprobe elemental microanalysis" . J. Neurochem. , 62 : 134 – 146 .
   PubMed Web of Science ®Google Scholar
• Turnbull , S. , Tabner , B.J. , El-Agnaf , O.M. , Moore , S. , Davies , Y. and Allsop , D. 2001 . "alpha-Synuclein implicated in Parkinson's disease catalyses the formation of hydrogen peroxide in vitro" . Free Radic. Biol. Med. , 30 : 1163 – 1170 .
   PubMed Web of Science ®Google Scholar
• Youdim , M.B.H. 2001 . "Is neuroprotection possible in neurodegenerative diseases?" . Ann. N.Y. Acad. Sci. , 939 : 472 – 474 .
   Google Scholar
• Youdim , M.B.H. and Riederer , P. 2002 . "Iron in the brain, normal and pathological" ” . In Encyclopedia of Neuroscience , Amsterdem, , Netherlands : Elsevier Science B.V. .
   Google Scholar
• Youdim , M.B.H. , Grunblatt , E. and Mandel , S. 1999 . "The pivotal role of iron in NF-kappa B activation and nigrostriatal dopaminergic neurodegeneration. Prospects for neuroprotection in Parkinson's disease with iron chelators" . Ann. N.Y. Acad. Sci. , 890 : 7 – 25 .
   PubMed Web of Science ®Google Scholar
• Youdim , M.B.H. , Grunblatt , E. , Levites , Y. and Mandel , S. , eds. 2001 . Drugs to prevent cell death in Parkinson's disease: neuroprotection against oxidative stress and inflammatory gene expressions , Vol. 86 , Philadelphia : Lippincott Williams and Wilkins .
   Google Scholar
• Zhou , B. , Westaway , S.K. , Levinson , B. , Johnson , M.A. , Gitschier , J. and Hayflick , S.J. 2001 . "A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome" . Nat. Genet. , 28 : 345 – 349 .
   PubMed Web of Science ®Google Scholar